Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
OptiBiotix Health ( (GB:OPTI) ) has shared an announcement.
OptiBiotix Health plc has announced the launch of its SlimBiome® product in Hydroxycut, a leading weight loss supplement brand in the USA. This collaboration marks a significant milestone for OptiBiotix, as it introduces its appetite-reducing product to a large market, potentially boosting sales and shareholder value. The product, marketed as ‘Hydroxycut Hunger Control,’ is available online and in major retail outlets like Walmart, and is backed by studies showing significant hunger reduction. This launch is expected to enhance OptiBiotix’s presence in the weight management industry and strengthen its brand recognition globally.
More about OptiBiotix Health
OptiBiotix Health plc, established in March 2012, operates in the life sciences sector, focusing on developing compounds that modify the human microbiome to prevent and manage diseases and promote wellness. The company collaborates with international food and healthcare supplement companies to incorporate its microbiome modulators into various food and drink products. OptiBiotix also develops its own consumer supplements and health products, targeting obesity, cardiovascular health, and diabetes.
Average Trading Volume: 295,848
Technical Sentiment Signal: Sell
Current Market Cap: £10.59M
For a thorough assessment of OPTI stock, go to TipRanks’ Stock Analysis page.